Загрузка...
Do immune checkpoint inhibitors need new studies methodology?
Immune checkpoint inhibitors (ICI) have widely reshaped the treatment paradigm of advanced cancer patients. Although multiple studies are currently evaluating these drugs as monotherapies or in combination, the choice of the most accurate statistical methods, endpoints and clinical trial designs to...
Сохранить в:
| Опубликовано в: : | J Thorac Dis |
|---|---|
| Главные авторы: | , , , , , , , , , |
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
AME Publishing Company
2018
|
| Предметы: | |
| Online-ссылка: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5994495/ https://ncbi.nlm.nih.gov/pubmed/29951307 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.21037/jtd.2018.01.131 |
| Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|